The IVD Base: DBIL, TBIL - Vietnam Registration 240002057/PCBB-HCM
Access comprehensive regulatory information for The IVD Base: DBIL, TBIL in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loแบกi B medical device is registered under number 240002057/PCBB-HCM. The authorized representative in Vietnam is CรNG TY TNHH SIEMENS HEALTHCARE.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
240002057/PCBB-HCM
000.00.19.H29-240828-0042
Theo theo phแปฅ lแปฅc
Theo phแปฅ lแปฅc
Technical Details
Atellica CH D_TBiL: The Atellica CH Diazo Total Bilirubin (D_TBil) test is used for in vitro diagnosis to quantify total bilirubin in human serum and plasma by the Atellica CH Analyzer. The measured value of total bilirubin (a compound formed in the normal and abnormal breakdown of red blood cells) is used in the diagnosis and treatment of liver, hemolysis, and metabolic disorders, including hepatitis and obstructive jaundice. Atellica CH D_DBiL: The Atellica CH Diazo Direct Bilirubin (D_DBil) test is used for in vitro diagnosis to quantify direct bilirubin in human serum and plasma by the Atellica CH Analyzer. The measured value of direct bilirubin (a compound formed in the normal and abnormal breakdown of red blood cells) is used in the diagnosis and treatment of liver, hemolysis, and metabolic disorders, including hepatitis and obstructive jaundice.
Dates and Status
Sep 11, 2024